FDA Holds Sponsors Accountable for Post-Marketing Studies

FDA Commissioner Scott Gottlieb said the agency is committed to ensuring “timely completion” of post-marketing studies by drug sponsors in a statement about the agency’s latest report on the status of reviews.
Source: International Pharmaceutical Regulatory Monitor